BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3455665)

  • 1. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
    Young MR; Newby M
    Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR; Young ME; Wepsic HT
    Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma.
    Young MR; Newby M; Meunier J
    Cancer Res; 1985 Aug; 45(8):3918-23. PubMed ID: 3860290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
    Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
    Mahan M; Meunier J; Newby M; Young MR
    J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR; Hoover CS
    J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
    Young MR; Newby M
    J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior.
    Young MR; Okada F; Tada M; Hosokawa M; Kobayashi H
    Invasion Metastasis; 1991; 11(1):48-57. PubMed ID: 2061004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
    Young MR; Knies S
    J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
    Young MR; Young ME; Kim K
    Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells.
    Young MR; Young ME; Lozano Y; Bagash JM
    Invasion Metastasis; 1992; 12(5-6):253-63. PubMed ID: 1298738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen degradation by metastatic variants of Lewis lung carcinoma: cooperation between tumor cells and macrophages.
    Henry N; van Lamsweerde AL; Vaes G
    Cancer Res; 1983 Nov; 43(11):5321-7. PubMed ID: 6352018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
    Maca RD
    J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma.
    Duffie GP; Young MR
    J Leukoc Biol; 1991 Jan; 49(1):8-14. PubMed ID: 1984486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of pinocytosis and the production of prostaglandin E2 by hepatic and peritoneal resident macrophages in mice].
    Mavier P; Préaux AM; Zafrani ES; Vasconcelos AW; Rosenbaum J; Dhumeaux D
    Gastroenterol Clin Biol; 1985; 9(6-7):508-15. PubMed ID: 3860455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
    Maca RD
    Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 does not inhibit tumoricidal activity of mouse macrophages against adherent tumor cells.
    Utsugi T; Fidler IJ
    J Immunol; 1991 Mar; 146(6):2066-71. PubMed ID: 2005391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 regulation of tumoristatic factor production by macrophage-like P388D1 cells.
    Young MR; Simmermaker JA
    J Natl Cancer Inst; 1984 Oct; 73(4):959-62. PubMed ID: 6592390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
    Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
    J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma.
    Eisenbach L; Segal S; Feldman M
    J Natl Cancer Inst; 1985 Jan; 74(1):77-85. PubMed ID: 3855489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.